𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Intracarotid infusion of cis-diamminedichloroplatinum in the treatment of recurrent malignant brain tumors

✍ Scribed by Lynn G. Feun; Sidney Wallace; David J. Stewart; Vincent P. Chuang; Wai-Kwan A. Yung; Milam E. Leavens; M. Andrew Burgess; Niramol Savaraj; Robert S. Benjamin; Sue Ellen Young; Rosa Ann Tang; Stanley Handel; Giora Mavligit; William S. Fields

Publisher
John Wiley and Sons
Year
1984
Tongue
English
Weight
667 KB
Volume
54
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Cis-diamminedichloroplatinum (II) admini
Cis-diamminedichloroplatinum (II) administered by 24-hour infusion in the treatment of patients with advanced upper aerodigestive cancer
✍ Edward T. Creagan; Judith R. O'Fallon; John E. Woods; James N. Ingle; Allan J. S πŸ“‚ Article πŸ“… 1983 πŸ› John Wiley and Sons 🌐 English βš– 364 KB πŸ‘ 2 views

A regression rate of 12% (4/33) among patients with advanced upper aerodigestive carcinomas who received an intravenous regimen of cis-diamminedichloroplatinum, 90 mg/mz/24 hours each three weeks was achieved. The response rate was 13% (3/23) among patients with typical squamous cell carcinoma. Most

Temozolomide in the treatment of recurre
Temozolomide in the treatment of recurrent malignant glioma
✍ Susan M. Chang; Philip Theodosopoulos; Kathleen Lamborn; Mary Malec; Jane Rabbit πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 85 KB πŸ‘ 1 views

## Abstract ## BACKGROUND Options for chemotherapy at the time of recurrence in patients with malignant glioma are limited. The authors describe the efficacy and safety results of their institution's open‐label, compassionate‐use protocol of temozolomide for patients with recurrent malignant gliom